ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00555204

Public ClinicalTrials.gov record NCT00555204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 2:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study Using a Bayesian Adaptive Design to Evaluate the Efficacy and Safety of ABT-089 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Study identification

NCT ID
NCT00555204
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abbott
Industry
Enrollment
337 participants

Conditions and interventions

Interventions

  • ABT-089 Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
May 31, 2009
Completion
Not listed
Last update posted
Aug 22, 2011

Started 2007

United States locations

U.S. sites
42
U.S. states
16
U.S. cities
41
Facility City State ZIP Site status
Not listed Phoenix Arizona 85006
Not listed Sun City Arizona 85351
Not listed Fresno California 93720
Not listed San Diego California 92108
Not listed Santa Ana California 92705
Not listed Santa Monica California 90404
Not listed Hamden Connecticut 06518
Not listed New Haven Connecticut 06510
Not listed Brooksville Florida 34613
Not listed Delray Beach Florida 33445
Not listed Fort Myers Florida 33901
Not listed Hallendale Florida 33009
Not listed Hialeah Florida 33016
Not listed Largo Florida 33770
Not listed Miami Florida 33180
Not listed Palm Beach Gardens Florida 33418
Not listed Sunrise Florida 33351
Not listed Tampa Florida 33613
Not listed West Palm Beach Florida 33407
Not listed West Palm Beach Florida 33409
Not listed Indianapolis Indiana 46260
Not listed Paducah Kentucky 42003
Not listed Pittsfield Massachusetts 01201
Not listed Grand Rapids Michigan 49503
Not listed St Louis Missouri 63141
Not listed Long Branch New Jersey 07740
Not listed Nutley New Jersey 07110
Not listed Princeton New Jersey 08540
Not listed Ridgewood New Jersey 07450
Not listed Albany New York 12208
Not listed New York New York 10021
Not listed Staten Island New York 10312
Not listed The Bronx New York 10454
Not listed Hickory North Carolina 28601
Not listed Winston-Salem North Carolina 27104
Not listed Centerville Ohio 45459
Not listed Cleveland Ohio 44106
Not listed Jenkintown Pennsylvania 19046
Not listed Norristown Pennsylvania 19401
Not listed San Antonio Texas 78229
Not listed Wichita Falls Texas 76309
Not listed Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00555204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2011 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00555204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →